FOLH1 and prostate cancer: Current, most clinically used PSMA radiotracers are 68Ga-PSMA-11, 18F-PSMA-1007, and 18F-DCFPyL, which show superiority to conventional imaging and other PET radiotracers, such as fluciclovine and cholines in recurrent prostate cancer [6].